All
Novel patch delivers local anesthesia with convenience, quickness, safety
September 1st 2004New York-An easy-to-use, self-warming patch containing lidocaine and tetracaine provides effective local anesthesia for minor dermatological procedures in adult patients, said Brian Berman, M.D., Ph.D, at the American Academy of Dermatology's Academy '04 meeting here.
Melasma treatments - from frustration to fruition?
September 1st 2004Eilat, Israel - For the last 50 years, hydroquinone has been the reference of treatment in hyperpigmentations, and more recently, combination formulas, peelings and adjuvant therapies including sunscreens containing the drug, show promise. However, topical agents have yet to prove a constant and uncontested efficiency, said Daphne Thioly-Bensoussan M.D., during the 28th Annual Meeting of the Israeli Conference of Dermatology and Venerology.
Tacrolimus bests pimecrolimus for treatment of AD, study says
September 1st 2004Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.
Savvy physician takes walk on entrepreneurial side
September 1st 2004Finally - and perhaps most crucial, says Dr. Goode - there is this question: Is there anything like the new device available? Because if there isn't, the new device could draw the attention of manufacturing or distributing companies.
Success starts outside operating room
August 1st 2004Stanford, Calif. - To be truly successful in a cosmetic surgery dermatology practice, it is important to think beyond garnering surgical ability. While such ability is essential, it is not the only aspect of a practice that surgeons should think about, says David R. Harris, M.D., a clinical professor at Stanford University School of Medicine.
Attending to many aspects of patient pain
August 1st 2004Orlando, Fla. - Pain has several components - both sensory and emotional - and it is an experience that varies by individual. The ability to control pain effectively is crucial to a good dermatology practice. That was the message Christopher B. Zachary, F.R.C.P. presented recently at the Skin Disease Education Foundation Cosmetic Dermatology Symposium here.
Radiance FN finds special niche in facial augmentation
August 1st 2004Stanford, Calif. - Radiance FN (BioForm) is an excellent injectable material for augmentation of minor defects, particularly in the midface, although accumulating experience might point to additional roles for this relatively new addition to the filler armamentarium, says Hayes B. Gladstone, M.D.
Common fungal diseases can be tricky in kids
August 1st 2004Cleveland - When thinking of pediatric fungal diseases, the mind may immediately turn toward the scalp and the typical presentation of tinea capitis. Yet fungal diseases often masquerade in several forms in various areas of the body, making the dermatologist's job of diagnosis and treatment more complicated.
The many uses of vascular lasers
August 1st 2004Walnut Creek, Calif. - Current indications for vascular lasers include port wine stains, rosacea, telangiectasia, a variety of vascular lesions, warts, scars, leg veins, stretch marks and nonablative wrinkle reduction, says Jerome R. Potozkin, M.D., in private practice here.
Older drugs' photoreactivity cataloged
August 1st 2004Chicago - Tracking the photoreactivity of many medicines that predate U.S. Food and Drug Administration requirements in this area has been an inexact science, but it's becoming less so. That's because an extensive review released in a presentation at "Important Advances in Allergy-Immunology and Dermatology - From the Bench to the Bedside," a recent gathering of allergists, immunologists and dermatologists in Chicago hosted by Northwestern University, outlines photoreactivity data for more than 100 widely used drugs gleaned from more than 150 research articles
Steps to stop excessive sweating
August 1st 2004Stanford, Calif. - Reports of the efficacy of botulinum toxin type A (Botox, Allergan) injection for the management of focal hyperhidrosis are prompting more patients to seek treatment for excessive sweating, says Daniel Berg, M.D., who spoke on the topic at "The Next Step: Mastering Cutaneous Outpatient Procedures," a continuing education program held at Stanford University.